Expression of bioactive single-chain murine IL-12 in transgenic plants

Journal of Interferon and Cytokine Research

Volumn 28, Issue 6, 2008, Pages 381-391

  Liu, Jianyun ^a,b   Dolan, Maureen C ^a   Reidy, Michael ^a,b   Cramer, Carole L ^a  

^a ARKANSAS STATE UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCAN DERIVATIVE; GLYCOPROTEIN; HETERODIMER; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISULFIDE BOND; DRUG SYNTHESIS; GENE EXPRESSION; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPLEEN CELL; TOBACCO; TRANSGENIC PLANT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; MICE; MICE, INBRED C57BL; NEOPLASMS; PLANT ROOTS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; RHIZOBIUM RADIOBACTER; TOBACCO;

ANIMALIA; MURINAE; NICOTIANA OBTUSIFOLIA;

EID: 46449102360     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0129     Document Type: Article

References (52)

1. Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW. 2003. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J Virol 77:5589-5597.
2. Anderson R, Macdonald I, Corbett T, Hacking G, Lowdel, MW, Prentice HG. 1997. Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus. Hum Gene Ther 8:1125-1135.
3. Bakker H, Schijlen E, de Vries T, Schiphorst WE, Jordi W, Lommen A, Bosch D, van Die I. 2001. Plant members of the alpha1→3/4-fucosyltransferase gene family encode an alpha1→4fucosyltransferase, potentially involved in Lewis(a) biosynthesis, and two core alpha1→3fucosyltransferases. FEBS Lett 507:307-312.
4. Becker D. 1990. Binary vectors which allow the exchange of plant selectable markers and reporter genes. Nucleic Acids Res 18:203.
5. Bermúdez-Humarán LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R, Le Loir Y. 2003. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 71:1887-1896.
6. Boyer JD, Cohen AD, Ugen KE, Edgeworth RL, Bennett M, Shah A, Schumann K, Nath B, Javadian A, Bagarazzi ML, Kim J, Weiner DB. 2000. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. AIDS 14:1515-1522.
7. Carra G, Gerosa F, Trinchieri G. 2000. Biosynthesis and posttranslational regulation of human IL-12. J Immunol 164:4752-4761.
8. Carrington JC, Freed DD. 1990. Cap-independent enhancement of translation by a plant potyvirus 5′ nontranslated region. J Virol 64:1590-1597.
9. Chen H, Nelson RS, Sherwood JL. 2004. Enhanced recovery of transformants of Agrobacterium tumefaciens after freeze-thaw transformation and drug selection. Biotechniques 16:664-670.
10. Chrispeels MJ, Raikhel NV. 1991. Lectins, lectin genes, and their role in plant defense. Plant Cell 3:1-9.
11. Colombo MP, Trinchieri G. 2002. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13:155-168.
12. Cramer CL, Boothe JG, Oishi KK. 1999. Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr Top Microbiol Immunol 240:95-118.
13. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RW. 2004. Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7:152-158.
14. Foss DL, Moody MD, Murphy KP Jr., Pazmany C, Zilliox MJ, Murtaugh MP. 1999. In vitro and in vivo bioactivity of single-hain interleukin-12. Scand J Immunol 50:596-604.
15. Galarza JM, Latham T, Cupo A. 2005. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 18:365-372.
16. Gately MK, Brunda M J. 1995. Interleukin-12: a pivotal regulator of cell-mediated immunity. Cancer Treat Res 80:341-366.
17. Gaume A, Komarnytsky S, Borisjuk N, Raskin I. 2003. Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep 21:1188-1193.
18. Gomord, V, Faye, L. 2004. Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol 7:171-181.
19. + T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol 167:156-162.
20. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, Gately MK. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88:4143-4147.
21. Guillon S, Tremouillaux-Guille, J, Pati PK, Rideau M, Gantet P. 2006a. Harnessing the potential of hairy roots: dawn of a new era. Trends Biotechnol 24:403-409.
22. Guillon S, Tremouillaux-Guiller J, Pati PK, Rideau M, Gantet P. 2006b. Hairy root research: recent scenario and exciting prospects. Curr Opin Plant Biol 9:341-346.
23. Gutierrez-Ortega A, Avila-Moreno F, Saucedo-Arias LJ, Sanchez-Torres C, Gomez-Lim MA. 2004. Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. Biotechnol Bioeng 85:734-740.
24. Gutierrez-Ortega A, Sandoval-Montes C, Olivera-Flores TJ, Santos-Argumedo L, Gomez-Lim MA. 2005. Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res 14:877-885.
25. Ha SJ, Chang J, Song MK, Suh YS, Jin HT, Lee CH, Nam GH, Choi G, Choi KY, Lee SH, Kim WB, Sung YC. 2002. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nat Biotechnol 20:381-386.
26. Jiang C, Magee DM, Cox RA. 1999. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect Immun 67:2996-3001.
27. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827-845.
28. Kwon TH, Seo JE, Kim J, Lee JH, Jang YS, Yang MS. 2003. Expression and secretion of the heterodimeric protein interleukin-12 in plant cell suspension culture. Biotechnol Bioeng 81:870-875.
29. Lam E, Benfey PN, Gilmartin PM, Fang RX, Chua NH. 1989. Site-specific mutations alter in vitro factor binding and change promoter expression pattern in transgenic plants. Proc Natl Acad Sci USA 86:7890-7894.
30. Leutenegger CM, Boretti FS, Mislin CN, Flynn JN, Schroff M, Habel A, Junghans C, Koenig-Merediz SA, Sigrist B, Aubert A, Pedersen NC, Wittig B, Lutz H. 2000. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol 74:10447-10457.
31. Lieschke GJ, Rao PK, Gately MK, Mulligan RC. 1997. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat Biotechnol 15:35-40.
32. Ma, JK-C, Drake PMW, Christou P. 2003. The production of recombinant pharmaceutical proteins in plants Nat Rev Genet 4:794-805.
33. Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR. 1999. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 162:114-121.
34. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rude E, Germann T. 1993. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 23:2202-2208.
35. Medina-Bolivar F, Cramer C. 2004. Production of recombinant proteins by hairy roots cultured in plastic sleeve bioreactors. Methods Mol Biol 267:351-363.
36. Medina-Bolivar, F, Wright R, Funk V, Sentz D, Barroso L, Wilkins TD, Petri W Jr., Cramer CL. 2003. A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Vaccine 21:997-1005.
37. Medrano G, Reidy MJ, Liu J, Ayala J, Dolan MC, Cramer CL. 2008. Rapid system for evaluating bioproduction capacity of complex pharmaceutical proteins in plants. In: Methods in biotechnology recombinant pharmaceutical proteins from plants. Humana Press, Totowa, In press.
38. Noguchi Y, Richards EC, Chen YT, Old LJ. 1995. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 92:2219-2223.
39. Putalun W, Taura F, Qing W, Matsushita H, Tanaka H, Shoyama Y. 2003. Anti-solasodine glycoside single-chain Fv antibody stimulates biosynthesis of solasodine glycoside in plants. Plant Cell Rep 2:344-349.
40. ROOTec Bioactives GmbH, founded May 2005; Basel, Switzerland, by Drs. Hélène Corbière-Divialle, Alain Denis Meyer, and Peter Ripplinger. Available at www.RooTec.com
41. Salem ML, Gillanders WE, Kadima AN, El Naggar S, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ. 2006. Novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity [Review]. J Interferon Cytokine Res 26:593-608.
42. Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H. 2007. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 5:657-663.
43. Shanks JV, Morgan J. 1999. Plant 'hairy root' culture. Curr Opin Biotechnol 10:151-155.
44. + T cell-mediated protective immunity against herpes simplex virus-2 challenge J Immunol 162:2912-2921.
45. Sivakumar G. 2006. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots. Biotechnol J 1:1419-1427.
46. Sparrow PAC, Irwin JA, Dale PJ, Twyman RM, Ma JK-C. 2007. Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res 16:147-161.
47. Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, Woodard SL, Beifuss KK, Horn ME, Delaney DE, Tizard IR, Howard JA. 2001. Plant-based vaccines: unique advantages. Vaccine 19:2742-2748.
48. Takehara K, Kikuma R, Ishikawa S, Kamikawa M, Nagata T, Yokomizo Y, Nakamura M. 2002. Production and in vivo testing of a recombinant bovine IL-12 as an adjuvant for Salmonella typhimurium vaccination in calves. Vet Immunol Immunopathol 86:23-30.
49. Tretter V, Altmann F, Marz L. 1991. Peptide-N4-(N-acetyl-beta- glucosaminyl) asparagine amidase F cannot release glycans with fucose attached alpha 1→3 to the asparagine-linked N-acetylglucosamine residue. Eur J Biochem 199:647-652.
50. Trinchieri G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
51. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146:3074-3081.
52. Zagozdzon R, Golab J, Mucha K, Foroncewicz B, Jakobisiak M. 1999. Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo. Int J Mol Med 4:645-648.